Results 221 to 230 of about 64,045 (290)

Novel therapeutic strategies to restore vision in ocular hypotony (STRETCH): results from a prospective pilot series. [PDF]

Br J Ophthalmol
Orsine Murta Dias K, Yang E, Calcagni A, Kawa JR, Gooch J, Shah D, Khalil R, Sutaria A, Jayaram H, Gazzard G, Wickham L, Petrushkin H.   +11 more
europepmc   +1 more source

Comparative efficacy of different treatment modalities in the management of macular oedema in retinitis pigmentosa: a systematic review and network meta-analysis. [PDF]

BMJ Open Ophthalmol
Yang HA, Jheng WL, Hwang YS, Wu WC, Lai CC, Chou HD, Kang EY, Liu L, Chao AN, Chen YT, Chen KJ, Chen YH.   +11 more
europepmc   +1 more source

Twelve‑month Response and Safety of Intravitreal Dexamethasone Implant in Treatment‑Naïve and Recalcitrant Cystoid Macular Edema Secondary to Branch Retinal Vein Occlusion (TREAT-BRVO Study). [PDF]

Clin Ophthalmol
Chakraborty S, Sheth JU, Ganguly S, Reddy P.   +3 more
europepmc   +1 more source

Glaucoma Management in High Myopia: A Case of Hypotony-Related Serous Retinal Detachment Following Trabeculectomy and Successful Treatment with Intravitreal SF6 Gas. [PDF]

Turk J Ophthalmol
Kaderli A, Tekin O, Kaya Bal C, Tamer Kaderli S, Sül S.   +4 more
europepmc   +1 more source

Optic Nerve Alterations Following Intravitreal Injection and Laser in Infants With Retinopathy of Prematurity. [PDF]

Invest Ophthalmol Vis Sci
Deng X, Zhang S, Zhang Y, Gao X, Shen Y, Shen L, Mao J.   +6 more
europepmc   +1 more source

Treatment of spontaneous hyphema in Fuch's heterochromic iridocyclitis with intravitreal anti-VEGF ranibizumab. [PDF]

BMJ Case Rep
Guo G, Papantoniou L, Smith J, Ong K.
europepmc   +1 more source

Vitrectomy Status Alters Early Intravitreal Drug Distribution: An Ex Vivo PET-CT Study. [PDF]

Invest Ophthalmol Vis Sci
Wohlfart S, Roettgen HG, Junker N, Augustin VA, Ackermann BC, Geisweid L, Auffarth GU, Mier W, Uhl P, Hammer M.   +9 more
europepmc   +1 more source

Disproportionality analysis of off-label intravitreal bevacizumab in the FDA Adverse Event Reporting System database. [PDF]

Ther Adv Drug Saf
Contreras-Salinas H, Vázquez-Beltrán JC, García-Sánchez G, Quirarte-Justo S, Gómez-Macías SDC, Rodríguez-Herrera LY.   +5 more
europepmc   +1 more source

Early intraocular pressure kinetics after intravitreal aflibercept 8 mg (0.07 mL) versus aflibercept 2 mg (0.05 mL) in nonglaucomatous eyes: a prospective comparative study. [PDF]

Int J Retina Vitreous
Licht A, Schneider A, Romanou V, Mirshahi A.   +3 more
europepmc   +1 more source

Intravitreal Onchocerca sp. With Concomitant Cerebral MRI Lesion: A Case Report. [PDF]

Am J Case Rep
Supanji S, Felisha HF, Romdhoniyyah DF, Nursawitri S, Syahriza S, Farzana IAK, Basalamah YH, Rizqia Indrayanti S, Milastuti N, Amalia K, Setyawan NH, Diptyanusa A, Hadianto T, Satiti S, Prayogo ME, Wardhana FS, Sasongko MB, Astuti RRUNW, Ridwan Y.   +18 more
europepmc   +1 more source